Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Arcturus Therapeutics Holdings Inc (NQ: ARCT )

43.81 USD -1.36 (-3.01%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 345,349
Open 45.21
Bid (Size) 43.27 (1)
Ask (Size) 44.20 (5)
Prev. Close 45.17
Today's Range 43.34 - 45.41
52wk Range 24.87 - 129.71
Shares Outstanding 26,327,077
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 
From Business Wire News Releases
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 3b Study for ARCT-154, a Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and Other
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and... 
From Business Wire News Releases

Performance

YTD
-10.41%
-10.41%
1 Month
-13.40%
-13.40%
3 Month
+32.96%
+32.96%
6 Month
+14.57%
+14.57%
1 Year
-12.55%
-12.55%

More News

Read More
Arcturus Therapeutics Announces Meeting with President of Vietnam and CEO of Vingroup to Discuss Expansion of COVID-19 Vaccine Collaboration
From Business Wire News Releases
Bullish Two Hundred Day Moving Average Cross - ARCT
Tags Stocks
From Market News Video
Arcturus Therapeutics Announces Approval from Vietnam Ministry of Health to Proceed into Phase 2 and Phase 3a for ARCT-154, Next Generation STARR™ mRNA Vaccine Targeting SARS-CoV-2 Delta Variant and O
From Business Wire News Releases
3 Beaten-Down Stocks Cathie Wood Is Buying That Wall Street Thinks Will Skyrocket
Tags Market News TDOC ARKG
From Motley Fool
Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You?
Tags Market News ARCT PFE
From Motley Fool
Analysts Expect 42% Gains Ahead For The Holdings of WDNA
Tags ETFs
From ETF Channel
Stock Upgrades: Arcturus Therapeutics Shows Rising Relative Strength
From Investor's Business Daily
Merck Keeps M&A Mode On With Mirati, Biogen, mRNA Companies On Radar: FT
Tags News Rumors General
From Benzinga
Stocks Showing Improved Relative Strength: Arcturus Therapeutics
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.